Atlas Trials

Risk Adapted Beacopp Regimen for Standard and High Risk Hodgkin Lymphoma

Clinical trial NCT00305149 · COMPLETED

Trial details

NCT number
NCT00305149
Sponsor
Rambam Health Care Campus
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Classical Hodgkin LymphomaNodular SclerosisMixed CellularityLymphocyte DepletionLymphocyte Rich
Start date
1999-07-01
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.